Elhízás: vizsgálatok itt: Kína
249 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleFecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome
- Where
- Shanghai
- Életkor
- 20 év to 40 év
- People
- 411
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07746635 - 2. fázisNot yet taking people in KínaA Study to Evaluate the Safety and Efficacy of Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
- Where
- Luoyang
- Életkor
- 18 év to 65 év
- People
- 180
- Run by
- Hangzhou Sciwind Biosciences Co., Ltd.
See details and how to joinNCT07929298 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Beijing, Changchun, Hefei, Herbin, Huizhou, Jinan, Langfang, Luoyang, Nanjing, Pingxiang, Shanghai, Suzhou, Xianyang, Zhenjiang
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Beijing, Cangzhou, Changchun, Hefei, Herbin, Huizhou, Jinan, Kaifeng, Langfang, Luoyang, Nanjing, Ningbo, Pingxiang, Shanghai, Siping, Suzhou, Wuxi, Xi'an, Xianyang, Xuzhou, Yueyang, Zhenjiang
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus
- Where
- Baotou, Beijing, Changde, Changsha, Changzhou, Chengdu, Hefei, Huangshi, Jincheng, Jinzhou Shi, Langfang, Luoyang, Meihekou, Nanjing, Nanyang, Shanghai, Shantou, Shenyang, Shijiazhuang, Wuhan, Wuhu, Xianyang, Xuzhou, Yan’an, Yueyang, Zhumadian, Zibo
- Életkor
- 18 év and over
- People
- 351 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07775404 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Beijing, Changchun, Chengdu, Guangzhou, Huzhou, Nanjing, Ningbo
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - No phaseTaking peopleExplore the Weight Loss Effect of Amway "BODY TRIMMER"
- Where
- Shanghai
- Életkor
- 30 év to 65 év
- People
- 110
- Run by
- Amway (China) R&D Center
See details and how to joinNCT07924956 - No phaseTaking peopleDetermination of ED90 of Remimazolam Besylate Combined With Alfentanil for Gastroscopy Sedation in Obese Patients
- Where
- Jinan
- Életkor
- 18 év to 65 év
- People
- 120
- Run by
- Jianbo Wu
See details and how to joinNCT07925684 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or Obesity
- Where
- Beijing, Hefei, Huizhou, Nanchang, Nanjing, Zhengzhou
- Életkor
- 18 év and over
- People
- 432
- Run by
- Pfizer
See details and how to joinNCT07874633 - 3. fázisNot yet taking people in KínaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- Where
- Beijing, Bozhou, Cangzhou, Changzhou, Chongqing, Daqing, Ganzhou, Guangzhou, Jiaxing, Jinan, Liuzhou, Luoyang, Luzhou, Sanya, Shanghai, Shenyang, Shiyan, Suzhou, Wuhan, Xi'an, Xuancheng, Yuncheng, Zhengzhou
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07922330 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
- Where
- Hefei
- Életkor
- 18 év to 65 év
- People
- 126
- Run by
- Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT07102251 - 3. fázisTaking peopleA Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
- Where
- Beijing, Changchun, Hefei, Herbin, Huai'an, Huzhou, Jinan, Langfang, Luoyang, Nanjing, Ningbo, Shanghai, Shenyang, Shijiazhuang, Xianyang, Zhengzhou, Zibo
- Életkor
- 18 év and over
- People
- 300
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07670416 - 3. fázisTaking peopleA Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity
- Where
- Beijing, Changchun, Changzhou, Chongqing, Hangzhou, Harbin, Hefei, Hengshui, Huizhou, Huzhou, Jinan, Luoyang, Nanchang, Nanjing, Nantong, Ningbo, Pingxiang, Shanghai, Shijiazhuang, Shiyan, Tianjin, Wuhan, Xi'an, Zhengzhou, Zhenjiang
- Életkor
- 18 év and over
- People
- 300
- Run by
- Pfizer
See details and how to joinNCT07792954 - 3. fázisTaking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- Chengdu, Hefei, Jinan, Luoyang Shi, Nanjing, Ningbo, Qinhuangdao Shi, Tianjin
- Életkor
- 18 év and over
- People
- 2001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - 1. fázisTaking peopleStudy of UBT37034 Injection
- Where
- Changsha
- Életkor
- 18 év to 55 év
- People
- 40
- Run by
- The United Bio-Technology (Hengqin) Co., Ltd.
See details and how to joinNCT07873645 - No phaseNot yet taking people in KínaGut Microbiota-Based Clinical Study of Akkermansia Supplementation for Overweight and Obesity
- Where
- Nanchang
- Életkor
- 18 év to 60 év
- People
- 150
- Run by
- Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07898267 - 2. fázisNot yet taking people in KínaA Study to Evaluate Efficacy and Safety of BGM1812 Injection in Overweight or Obese Participants Without Diabetes
- Where
- Changsha
- Életkor
- 18 év to 55 év
- People
- 160
- Run by
- BrightGene Bio-Medical Technology Co., Ltd.
See details and how to joinNCT07918625 - 3. fázisTaking peopleA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Where
- Tainan, Taipei, Taoyuan
- Életkor
- 6 év to 17 év
- People
- 125 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672549 - 3. fázisTaking peopleA Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
- Where
- Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Lanzhou, Nanjing, Ningbo, Shanghai, Shenzhen, Suzhou, Wuhan, Xiamen, Xi’an
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07202884 · EU 2025-522514-23-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Beijing, Chengdu, Chongqing, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing, Shanghai, Tianjin, Zigong
- Életkor
- 18 év and over
- People
- 1035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - 3. fázisTaking peopleEfficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Where
- Beijing, Bengbu, Changchun, Changsha, Chongqing, Hangzhou, Hefei, Jinan, Luoyang, Nanjing, Ningbo, Shanghai, Suzhou, Tianjin, Wenzhou, Wuhan, Xianyang
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07353931 · EU 2025-523768-19-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Kunming, Lanzhou, Luoyang Shi, Nanchang, Nanjing, Nanning, Ningbo, Shanghai, Shenzhen, Suzhou, Wuxi, Xianyang
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Guiyang, Hefei, Huzhou, Jinan, Luoyang Shi, Luzhou, Nanchang, Nanjing, Ningbo, Shanghai, Wenzhou, Wuhan, Xianyang
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - 4. fázisTaking peopleAI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
- Where
- Chongqing, Hefei, Taiyuan, Wenzhou
- Életkor
- 18 év to 65 év
- People
- 285
- Run by
- The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07697391 - 3. fázisTaking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Changchun, Jinan, Luoyang Shi, Nanjing, Ningbo, Shijiazhuang, Tianjin
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00